Published in J Rheumatol on October 01, 1984
Reactive arthritis associated with cryptosporidium enteritis. Br Med J (Clin Res Ed) (1987) 1.21
Cervical Spine Involvement: A Rare Manifestation of Reiter's Syndrome. Open Rheumatol J (2014) 0.75
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum (1998) 12.36
Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) (1976) 3.07
Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum (1986) 2.39
Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest (1996) 2.39
Incomplete Reiter's syndrome: discriminating features and HL-A W27 in diagnosis. Ann Intern Med (1976) 2.34
PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest (1999) 2.14
Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) (1985) 2.01
Association of labial salivary gland histopathology with clinical and serologic features of connective tissue diseases. Arthritis Rheum (1990) 1.99
Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum (1981) 1.97
Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum (2001) 1.87
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) (2006) 1.77
Evidence that autoimmunity in man is a Mendelian dominant trait. Am J Hum Genet (1986) 1.74
Studies in familial systemic lupus erythematosus. Medicine (Baltimore) (1976) 1.70
Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med (1983) 1.68
An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis. Rheumatology (Oxford) (2007) 1.63
Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum (1992) 1.53
Genetic factors predisposing to autoimmune diseases. Autoimmune hemolytic anemia, chronic thrombocytopenic purpura, and systemic lupus erythematosus. Am J Med (1982) 1.51
Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science (1986) 1.50
Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum (1988) 1.47
Post-traumatic renal failure in military personnel in Southeast Asia. Experience at Clark USAF hospital, Republic of the Philippines. Am J Med (1972) 1.46
Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum (1999) 1.45
Complement component C4A and C4B levels in systemic lupus erythematosus: quantitation in relation to C4 null status and disease activity. J Rheumatol (1993) 1.42
Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study. Am J Med (1991) 1.40
Incomplete Reiter's syndrome: clinical comparisons with classical triad. Ann Rheum Dis (1979) 1.34
Pulmonary sarcoidosis: a prospective evaluation of glucocorticoid therapy. Ann Intern Med (1970) 1.33
Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. Am J Med (1986) 1.31
Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine (Baltimore) (1984) 1.30
Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med (1985) 1.28
Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum (1982) 1.27
Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest (1992) 1.21
HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis). Tissue Antigens (1999) 1.14
Revised criteria for the classification of rheumatoid arthritis. Bull Rheum Dis (1989) 1.14
Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med (1990) 1.12
HLA-DR characterization of a Chippewa Indian subpopulation with high prevalence of rheumatoid arthritis. Hum Immunol (1981) 1.11
Primary Sjögren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann Intern Med (1984) 1.11
Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses. J Immunol (1991) 1.11
Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts. J Immunol (2001) 1.11
Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma). J Clin Invest (1992) 1.11
The genetics of lupus. Curr Opin Rheumatol (1998) 1.10
Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies. Arthritis Rheum (1983) 1.08
The coexistence of rheumatoid arthritis with Reiter's syndrome and/or ankylosing spondylitis: a model of dual HLA-associated disease susceptibility and expression. J Rheumatol (1981) 1.08
Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum (1996) 1.08
Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases. J Immunol (1999) 1.07
BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians. Ann Rheum Dis (2009) 1.06
Multiplicity of antibodies in myositis sera. Arthritis Rheum (1984) 1.05
Primary Sjögren's syndrome in men. Clinical, serologic, and immunogenetic features. Am J Med (1986) 1.05
Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus. Immunogenetics (1985) 1.04
Family studies in HLA-B27 associated arthritis. Medicine (Baltimore) (1978) 1.04
Sjögren's syndrome. Influence of multiple HLA-D region alloantigens on clinical and serologic expression. Arthritis Rheum (1984) 1.04
Pulmonary sarcoidosis. Long-term follow-up of the effects of steroid therapy. Chest (1982) 1.04
Palmar fasciitis and arthritis with malignant neoplasms: a paraneoplastic syndrome. Semin Arthritis Rheum (1986) 1.03
Antibodies against Ku protein in sera from patients with autoimmune diseases. Clin Exp Immunol (1989) 1.03
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Ann Rheum Dis (2010) 1.02
Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome. J Rheumatol (1982) 1.02
Fixed and reproducible orthostatic proteinuria: results of a 20-year follow-up study. Ann Intern Med (1982) 1.02
Hypothyroidism presenting as a polymyositis-like syndrome. Report of two cases. Arthritis Rheum (1977) 1.01
Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am J Med (1992) 1.01
Seronegative spondylarthropathies. Bull Rheum Dis (1987) 1.00
The Jo-1 antibody system in myositis: relationships to clinical features and HLA. J Rheumatol (1982) 0.99
Familial occurrence of progressive systemic sclerosis and systemic lupus erythematosus. J Rheumatol (1984) 0.97
Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease. J Rheumatol (1984) 0.96
SPARC, an upstream regulator of connective tissue growth factor in response to transforming growth factor beta stimulation. Arthritis Rheum (2006) 0.96
Cross-reactive HLA antigens in B27-negative Reiter's syndrome and sacroiliitis. Johns Hopkins Med J (1977) 0.96
HLA-D related (DR) antigens in various kinds of myositis. Hum Immunol (1981) 0.96
Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population. Arthritis Rheum (1998) 0.95
Systemic lupus erythematosus: current state of the genetic hypothesis. Semin Arthritis Rheum (1984) 0.94
Familial systemic lupus erythematosus: immunogenetic studies in eight families. Medicine (Baltimore) (1983) 0.93
Primary biliary cirrhosis in systrmic sclerosis (scleroderma) and polymyositis. Johns Hopkins Med J (1974) 0.93
Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum (1988) 0.93
Amyloidosis in Reiter's syndrome. J Rheumatol (1979) 0.92
Studies of immune functions of patients with systemic lupus erythematosus. Arthritis Rheum (1979) 0.92
Methotrexate therapy in polymyositis. Ann Rheum Dis (1973) 0.92
Relationships of HLA-DR and MT antigens to autoantibody expression in systemic lupus erythematosus. Arthritis Rheum (1983) 0.92
IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus. J Rheumatol (2000) 0.91
Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitin autoantibodies in systemic lupus erythematosus. Arthritis Rheum (1993) 0.91
The centromere kinesin-like protein, CENP-E. An autoantigen in systemic sclerosis. Arthritis Rheum (1996) 0.91
Connective tissue disease in southeastern Georgia: a case-control study of etiologic factors. Am J Epidemiol (1989) 0.91
Association of fibrillin 1 single-nucleotide polymorphism haplotypes with systemic sclerosis in Choctaw and Japanese populations. Arthritis Rheum (2001) 0.91
Juvenile-onset chronic arthritis. Clinical and roentgenographic features of a unique HLA-B27 subset. Am J Med (1980) 0.91
C4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus. Immunogenetics (1989) 0.90
Rat liver histidyl-tRNA synthetase. Purification and inhibition by the myositis-specific anti-Jo-1 autoantibody. Biochem Biophys Res Commun (1984) 0.90
Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease. J Clin Invest (1989) 0.90
Immunogenetics of the neonatal lupus syndrome. Ann Intern Med (1983) 0.90
Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Bull Rheum Dis (1982) 0.90
The myocarditis of systemic lupus erythematosus: association with myositis. Ann Intern Med (1978) 0.89
Homozygosity for HLA-B27. Impact on rheumatic disease expression in two families. Arthritis Rheum (1977) 0.88
Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles. Arthritis Rheum (2000) 0.88
HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum (1990) 0.87
The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes. Arthritis Rheum (2009) 0.87
The genetics of rheumatic disease in man. Rheum Dis Clin North Am (1987) 0.87
Histocompatibility antigens in systemic lupus erythematosus. Arthritis Rheum (1976) 0.87
Poly(ADP)-ribose polymerase and susceptibility to systemic lupus erythematosus and primary antiphospholipid syndrome: comment on the article by Delrieu et al. Arthritis Rheum (2000) 0.86
Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. J Rheumatol (1998) 0.86
A major autoepitope is present on the amino terminus of a human SS-A/Ro polypeptide. J Autoimmun (1989) 0.86
Clinical presentations and molecular basis of complement C1r deficiency in a male African-American patient with systemic lupus erythematosus. Lupus (2011) 0.86
Primary Sjogren's syndrome and autoimmune hemolytic anemia in sisters. A family study. Am J Med (1983) 0.86
Fibrous myopathy. A rheumatic complication of drug abuse. Arthritis Rheum (1976) 0.85